Publications by authors named "I A Al-Bozom"
Article Synopsis
- - A 31-year-old patient experienced severe myocarditis, leading to cardiogenic shock and requiring mechanical support.
- - The patient's condition dramatically improved after receiving intravenous pulse steroids.
- - The successful treatment involved a coordinated effort from a multidisciplinary medical team, highlighting the importance of teamwork in critical care.
Article Synopsis
- - Neuroendocrine carcinoma from the urachus is very uncommon, with this case focusing on a 33-year-old man who had blood in his urine and was diagnosed with both adenocarcinoma and small cell neuroendocrine carcinoma.
- - At the time of diagnosis, the patient had widespread metastasis and was referred for chemotherapy, but his disease worsened despite the treatment.
- - Identifying the neuroendocrine carcinoma in urachal tumors is crucial because this type tends to have a poor prognosis and can lead to more aggressive disease progression.
Primary intrapulmonary thymoma (PIT), defined as the presence of thymoma tissue in the lung without an accompanying mediastinal component, is uncommon and so offers a diagnostic quandary. We describe the case of PIT in an 81-year-old man.
View Article and Find Full Text PDFBackground: In 2015, the term "SLIPPERS" was created to refer to a rare type of encephalomyelitis called CLIPPERS syndrome that affects the pons and sometimes other nearby structures, but in this case, it primarily affects the supratentorial region. This variation of the condition is responsive to treatment with steroids.
Case Description: We report the case of a patient who presented with seizures and visual field deficit and had typical radiological and histopathological characteristics of SLIPPERS syndrome.
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related morbidity and mortality worldwide. Immune checkpoint inhibitors (ICIs) including anti-PD-1 and anti-PD-L1 antibodies, have significantly changed the treatment outcomes with better overall survival, but only 15-40% of the patients respond to ICIs therapy. The search for predictive biomarkers of responses is warranted for better clinical outcomes.
View Article and Find Full Text PDF